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Abstract
In subacute cutaneous lupus eryhematosus (SCLE) the cutaneous antigens constitute the main source of Ro and La
autoantigens. The aim of this investigation was to demonstrate if UV light increases the availability of Ro autoantigen in the
skin, also the blocking effect of Ac-DEVD-CMK a caspase inhibitor was assessed. For this purpose newborn Balb/c mice were
UVB irradiated (5–30mJ/cm
2) equivalent to a moderate to severe sunburn. Animals were injected with monoclonal anti-Ro
antibodies from SCLE patients. Apoptosis was also induced by anti-Fas antibody injection. Skin samples were examined by
direct immunoﬂuoresence, by TUNEL,and the expression of caspase 3 byRT-PCR. Major ﬁndings of present studies were: 1.
UVB irradiation and anti-Fas induced apoptosis of keratinocytes. 2. Apoptosis redistribute the Ro antigen on cell surface and
is better triggered by Ro antibody. 3. The caspase 3 inhibitor Ac-DEVD-CMK decreases the availability of Ro autoantigen in
epidermis and prevents deposition of anti-Ro. In conclusion, the caspase pathway would be blocked to avoid anti-Ro
deposition along skin; this ﬁnding would be a prospect in the treatment of SCLE patients.
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Introduction
Casciola-Rosen et al. demonstrated that autoantigens
in lupus lacked of restriction to any subcellular
location and demonstrated that under apoptosis,
dying cells exhibited intracellular autoantigens on
the cell surface throughout a physiologic process
(Casciola-Rosen et al. 1994). In photosensitive
subsets of lupus erythematosus has been recognized
that apoptotic epidermal cells constitute a possible
source of autoantigens; whereas in systemic lupus
eythematosus (SLE) the apoptotic endothelial cells
and lymphocytes probably contribute to trigger
terminal-organ damage. Apoptosis guarantees the
cellular exchange; therefore a healthy individual
produce 1 £ 20
9Kg of cellular debris which is
cleaned by phagocytes; an inappropriate cleaning of
apoptotic material would triggers autoantibody pro-
duction in individuals genetically predisposed (Lorenz
et al. 2000). The epidermal release of intracellular
antigens would induce in situ the formation of immune
complexes that are related with the relapses of skin
lesions, in consequence, the study of the factors that
activate apoptosis are of clinical interest because
would allow to propose therapeutic strategies to
obtain clinical recovery. The aim of present study was
to induce a redistribution of the Ro antigen of the skin
in newborn Balb/c mice under UV irradiation, such
redistribution was monitored by anti-Ro antibodies
injected intraperitoneally. Additionally, we assess in
the skin the effect of the caspase inhibitor Ac-DEVD-
CMK on Ro/anti-Ro immune complex formation.
Material and methods
Balb/c mice groups
Animals were injected with anti-Ro antibody and
controls with normal IgG. Mice were grouped in
number of six according the following conditions: (A)
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UVB irradiated treated with Ac-DEVD-CMK. (D)
Injected with anti-Fas to induce apoptosis. (E)
Injected with anti-Fas and 2h later injected with
anti-Ro. (F) Anti-Fas treated with Ac-DEVD-CMK
and then injected with anti-Ro. Animals were injected
intra-peritoneal using a syringe in volumes adjusted to
50ml. The antibodies were administrated in a dosage
of 5mg/g of body weight. The caspase inhibitor Ac-
DEVD-CMK dissolved in DMSO adjusted to 20mM
was adjusted in PBS a ﬁnal volume of 50ml. A
monoclonal anti-Ro antibody obtained from CLB
(The Netherlands), or a polyclonal anti-Ro autoanti-
body from a SCLE patient, were used in all assays.
The monoclonal anti-Fas antibody was obtained from
Santa Cruz Biotechnology.
UV irradiation
Was carried out by means of a UV lamp (Black-Ray
UVL). The total dose of UV was 5–30mJ/cm
2, which
is equivalent in humans to a moderate to severe
sunburn.
Skin biopsies
Samples were obtained by means of a 2.5mm punch,
and were used for immunohistology and for RNA and
D N Ae x t r a c t i o nb yT R I s o l ,t h ee p i d e r m i sw a s
obtained by splitting with 10% dispase (Sigma). Direct
immunoﬂuorescence was done in a 4-mm slice of skin,
and immune deposition was detected by FITC-rabbit
anti human polyclonal IgG, or FITC-rabbit anti-
Mouse (Sigma) in animals injected with monoclonal
anti-Ro. TdT-mediated dUTP nick end labelling
(TUNEL): Nuclear stripping was performed with
10mM Tris–HCl, pH 8.0 followed by 15min in
20mg/ml proteinase K. Elongation of DNA fragments
was done by incubation with reaction mixture (DDW,
10XTdT buffer (30mM Tris base, 140mM sodium
cacodylate, pH 7.2, 1mM cobalt chloride, 1mM
DTT; 10% of the ﬁnal volume), ﬂuorescein-11-dUTP
(0.5mg dissolved in 1ml of 10mM Tris–HCl, pH
7.0), and TdT enzyme (0.3 enzyme units/ml).
Reaction was terminated by adding 300mM NaCl,
30mM sodium citrate, and pH 8.0. Finally the slides
were evaluated under ﬂuorescent microscopy to
differentiate the true green tag of apoptotic cells
from background incorporation, cells were counter-
stained with 0.5% propidium iodide, giving the non-
apoptotic nuclei develop a red stain. Oligonucleotides:
Caspase 3 forward 50-TCC AGT CGG AGG CCA
GAT CTG AG-30, backward 50-CTG AAG CCT
GCC TCC CGG GAT GA-30 [SNP000005036] and
G3PDH forward 50-TGA AGG TCG GTG TGA
ACG GAT TTG GC-30, backward 50-CAT GTA
GGC CAT GAG GTC CAC CAC-30 (Clontech).
Reverse-transcription/polymerase chain reaction
(RT-PCR)
RNA (250ng) was mixed with 200mM dNTP and
0.7mM of the backward primer and 5U/20mlo f
rTth/DNA polymerase and incubated at 708C for
10min. Ampliﬁcation of caspase 3 and G3PDH
cDNAs was carried out by PCR by addition of
0.15mM of the forward primer; using 30 cycles of
948C for 2min, 488C for 2min and 728C for 1.4min.
PCR products were electrophoresed in 0.8% agarose
containing 0.5mg/ml of ethidium bromide, and were
observed under UV light. Caspase 3 was also detected
by immunoperoxidase staining using an anti-caspase 3
antibody (Santa Cruz Biotechnology).
Results
Non-irradiated animals did not show epidermal
apoptosis; meanwhile UVB irradiated and anti-Fas
injected animals exhibited apoptotic features induced
in keratinocytes; such phenomenon was larger in UVB
irradiated animals. The expression of caspase 3 by RT-
PCR and immunohistochemistry of skin was evident
in animals UVB irradiated or treated with anti-Fas
antibody. On the other hand, the inhibitory effect of
Ac-DEVD-CMK on apoptosis was remarkable, since
apoptotic features were completely abolished in
animals under treatment with this caspase 3 inhibitor.
Under apoptosis Ro antigen became detectable in
epidermis, therefore apoptosis redistribute the Ro
antigen on cytoplasm and cell surface; therefore
apoptotic keratinocytes were better triggered by the
monoclonal or polyclonal anti-Ro antibodies. As
expected the caspase 3 inhibitor Ac-DEVD-CMK
decreased the availability of Ro autoantigen in
epidermis, such decrease resulted in abolishment of
anti-Ro deposition in epidermis, therefore skin
biopsies of animals treated with this caspase 3
inhibitor resulted negative. Controls injected with
normal human IgG were negative (Figure 1).
Discussion
Main results of present study demonstrate that UVB
irradiation and anti-Fas induces apoptosis of kerati-
nocytes and Ro antigen translocation to cell surface,
this facilitate the anti-Ro antibody triggering. We also
show that Ac-DEVD-CMK decreases the availability
Ro autoantigen and the anti-Ro deposition on the
skin. In lupus sun exposure induces apoptosis and
would contribute to the pathogenesis of skin lesions in
patients with cutaneous lupus phenotype (Kelly et al.
2006; Kuhn et al. 2006). The release of intact or
modiﬁed intracellular ribonucleoproteins including
Ro60 (Ramirez-Sandoval et al. 2003) promotes the
dendritic cell maturation and the production of
interferon, that is critical in autoantibody production
R. Herrera-Esparza et al. 164Figure 1. SCLE patient. 2. Skin biopsy of SCLE by immunoﬂuorescence showing lupus band of IgG. 3. SCLE with IgG deposition in cytoplasm of keratinocytes. 4. Anti-Ro60 of the SCLE detected in
human spleen extract by Western blot. 5. Positive ANA of the same patient. 6. Balb/c mouse injected with the human anti-Ro antibody from the SCLE patient. 7. Mouse skin biopsy non-UVB irradiated
negative for IgGdeposition. 8. UVB irradiated mouse show IgG resembling a lupus band. 9. UVBirradiated mouse show anti-Ro deposition in cytoplasm and cell surface of keratinocytes. 10–15 TUNEL
assays: 10 and 11 controls. 12. UVB irradiated mouse show epidermal apoptotic green tag. 13. Anti-Fas induced apoptosis. 14. Absence of apoptosis in UVB irradiated mouse treated with caspase 3
inhibitor. 15. Absence of apoptosis in anti-Fas injected mouse treated with caspase 3 inhibitor. 16. RT-PCR ampliﬁcation of caspase 3 (line1 DNA markers, line2 negative control, line3 UVB irradiated
mouse, line4 anti-Fas injected mouse, line5 UVB irradiated treated with caspase 3 inhibitor, line6 anti-Fas injected and treated with caspase 3 inhibitor). In the inferior part of the gel the G3PDH
housekeeping controls. 17–22 show the caspase 3 detection by immunoperoxidase. 17 and 18 negative controls. 19. UVB irradiated mouse shows extensive caspase 3 expression in epidermis and dermis.
20. Anti-Fas injected mouse with extensive expression of caspase 3. 21. UVB irradiated mouse treated with caspase 3 inhibitor. 22. Anti-Fas injected mouse treated with caspase 3 inhibitor.
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5and lupus relapses (Dall’era et al. 2005; Meller et al.
2005). Additionally, apoptosis induces secondary
necrosis and chemokine production that is followed
by recruitment and activation of autoimmune T cells
and IFN-alpha-producing plasmacytoid dendritic
cells creating a vicious circle. The local anti-Ro
antibody production and effectors cytokines and
leukocyte recruitment leads the development of
cutaneous lupus lesions. The importance of present
observation is that a caspase 3 inhibitor is capable to
block the release of intracellular ribonucleoproteins
such as Ro that is involved in SCLE pathogenesis; this
experimental therapy has been successfully used to
ameliorate kidney disease in a transgenic mouse model
of lupus nephritis (Seery et al. 2001).
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